Rhythm Pharmaceuticals appoints Kim Popovits to Board; Ed Mathers resigns

RHYTHM PHARMACEUTICALS, INC.

Kimberly J. Popovits elected as Class II director effective April 1, 2026 until 2028 annual meeting.
Edward T. Mathers resigned from Board same date; no disagreement with company cited.
Popovits is former Chairman/CEO of Genomic Health with >40 years life sciences experience.
Mathers served on Board since 2013; thanked for his strategic perspective and stewardship.
Popovits will receive standard non-employee director compensation per Company's policy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.